9to5 : EU antitrust regulator behind €13B Irish tax ruling isn’t done with Apple

EU antitrust regulator behind €13B Irish tax ruling isn’t done with Apple yet

EU antitrust regulator Margrethe Vestager is perhaps best known as the woman who instigated the investigation into Apple’s European tax arrangements, resulting in a ruling that Ireland must collect €13B ($14.4B) in back tax from the iPhone maker.
Now Vestager has outlined her remaining concerns with Apple in a new interview today …

The dispute over Apple’s Irish tax arrangements was a long-running one that isn’t over yet.
Apple had funneled almost the profits from its sales throughout Europe into Ireland, where a sweetheart tax deal saw the company pay an extremely low rate of tax. The investigation resulted in a ruling that the arrangement was illegal, but both Apple and Ireland appealed. Arguments were heard in September, with a ruling expected to take several months. Even that won’t be the end of it, the losing side almost certain to appeal to the European Court of Justice.
Nor is Vestager done when it comes to the tax arrangements of tech giants like Apple, she explained to The New York Times.
She is also working on policies to make companies pay more taxes in Europe and investigating how the companies use data to box out competitors.
The Irish tax ruling has so far addressed only the issue of the rate of tax Apple paid in Ireland, but Vestager questions whether it is even legal to channel profits from each European country there in the first place. Even without the sweetheart deal offered to Apple, Ireland still has extremely low rates of corporation tax, and Vestager believes that gives the Cupertino company an unfair advantage over local companies which pay higher taxes in the countries in which they are based.
The App Store is also in the sights of the EU antitrust regulator.
She remains focused on whether the largest technology companies squeezed out businesses that rely on them to reach customers. Amazon is under investigation for mistreating third-party sellers that offer products similar to what it sells. Apple is being questioned over accusations that it uses the App Store to harm rivals such as Spotify.
“Some of these platforms, they have the role both as player and referee, and how can that be fair?” she asked. “You would never accept a football match where the one team was also being the referee.”
In the streaming music example, the Cupertino company both sells Apple Music subscriptions and sets the rules for in-app subscriptions to rival Spotify. Spotify filed a formal complaint in Europe, complaining that Apple was giving itself an ‘unfair advantage at every turn.’
While part of the issue has been that Europe and the US have quite different attitudes to business regulation, Vestager believes this is now changing.
“Market forces are more than welcome, but we do not leave it to market forces to have the final say,” she said. “Markets are not perfect” […]
If anything, American authorities are coming around to share her tech skepticism. Federal, state and congressional investigators are scrutinizing the tech industry over unfair business practices. Ms. Vestager said she saw opportunities to collaborate, but was waiting to see how the inquiries unfolded.
“Obviously it’s very interesting to see what will come of it,” she said.

Barrons : Investment Firm Two Sigma Is Giving Investors Access to Its Software —

Top quantitative hedge funds rarely give outside investors a peek behind the curtain. But one firm known for its secretive process and strong returns is starting to open up—and expects to cash in.

Two Sigma, a New York-based investment manager that oversees more than $60 billion, recently began selling its software program Venn, which analyzes client positions and helps guide them toward better risk-management strategies, to the public. Among its early clients are Brown University, Prudential Financial (ticker: PRU) and the State of Wisconsin Investment Board. It is a sign that investment methods once considered cutting edge are increasingly filtering into the mainstream.

Other companies known for managing money have also expanded their software businesses in recent years. For example, Blackrock’s (BLK) Aladdin system is one of the dominant tools that institutions now use for risk management.

Two Sigma’s program can quickly pull in data about a client’s investment positions, and run analyses based on factors such as momentum and credit. As investors increasingly use factor methods to guide their decisions, the software can clue them in to areas where they may have too little or too much concentration, and help them adjust their risk. Users can see how their positions would have performed in prior periods, including recessions and financial shocks. Two Sigma is working on an update that will let investors test investment returns and correlations based on market shocks, such as escalations in the trade war.

“There are a small number of investors who can access our funds today, but there are thousands of other investors out there who have no relationship with us” that could benefit from Two Sigma’s technology, Jake Dwyer, general manager of Venn, said in an interview with Barron’s. “How can we offer something that allows them to engage with us in a scalable way to address needs across their portfolio without having to deal with the capacity constraints of managing a product? Software scales infinitely in that respect.”

There is a free version of the software and a professional one. The pro version costs $50,000 a year or $5,000 a month. Two Sigma now has more than 400 clients on the platform, including previous clients who had been using it before it was opened to wider distribution. About 30 Two Sigma employees are working on the product. It is segregated from Two Sigma’s funds so that Two Sigma investment managers can’t use client data from Venn to aid trading decisions.

Dwyer sees Venn as much more than a pet project alongside the firm’s better-known hedge fund and private-equity businesses. There are 30,000 investment managers managing $70 trillion in assets that could use a product like this, Dwyer estimates. “It’s a significant market opportunity and one that we wouldn’t enter into if we didn’t feel like it had the opportunity to really move the needle in terms of our overall business revenue,” he said.

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • CRMT +10.2%, CLVS +6.9%, AMC +5.7%, ASND +5.2%, NOW +4.3%, JKS +4.2%, BILI +3.8%, OKTA +2.4%, MDT +2%, WUBA +1%, SPLK +0.9%, CNK +0.9%, TMO +0.7%
  • Gapping down:
    • KRTX -11.5%, WWD -6.1%, DHT -5.6%, GSX -5.6%, HD -5.1%, EGHT -3.9%, M -3.4%, ASH -3.4%, PFGC -3.2%, EFC -3.1%, ZTO -2.5%, LOW -2.3%, ROKU -2.1%, I -1.9%, DUK -1.8%, KRNT -1.7%, SPCE -1.2%, ARMK -1%, ADS -0.9%, TGT -0.7%

FT : Alibaba listing marks critical test for both Hong Kong and Beijing Bankers

Alibaba listing marks critical test for both Hong Kong and Beijing
Bankers push ahead with the year’s biggest equity raising despite street violence

Alibaba’s decision to push ahead with its Hong Kong stock market listing despite worsening unrest came as a surprise to some of the city’s most seasoned investment bankers.

Just a few weeks ago a senior executive at a Hong Kong investment bank scoffed at the idea of the deal happening before the end of the year, given the dramatic scenes on the streets. “They want to see some of this craziness subside,” the banker said of Alibaba, adding: “They don’t really need the money.”

That same banker is now helping the Chinese ecommerce giant carry out the world’s biggest equity raising this year, worth up to $13.4bn. Before the offer was confirmed last week, a senior executive at another bank hinted he would be willing to place a large bet against it happening in 2019, citing its size and the tight timetable.

Alibaba’s debut is moving ahead despite increasingly violent clashes between police and protesters in the Asian financial hub, which have prompted the company itself to tell Hong Kong employees they can work from home. Pricing is expected on Wednesday. The deal’s backers are hoping a speedy listing will minimise risks from the territory’s most serious political crisis since Britain handed sovereignty to China 22 years ago.

The deal has already attracted orders that are a multiple of the number of shares on offer and the company will stop building its order book earlier than scheduled as a result, according to a person familiar with the deal. Significant interest from Asian sovereign wealth funds and Chinese institutions suggests the images of violence and unrest have done little to dent investor demand.

Still, some observers have questioned the timing, given gloomy market sentiment. The benchmark Hang Seng index dropped almost 5 per cent last week, the second worst performance in the world, before recovering to sit more than 1 per cent up on Tuesday afternoon. But other veteran market-watchers argue that the weak backdrop may actually strengthen the case for the offering from Beijing’s perspective.

“The political situation has clearly got worse and it’s a big deal in weak market conditions,” said Fraser Howie, an independent analyst. “But it’s in China’s interest to maintain Hong Kong as a financial centre. If this goes through, China can say ‘Hong Kong is still functioning, we haven’t closed things down’.”

Alibaba originally filed for a Hong Kong listing in June, hoping to raise up to $20bn but the offering stalled amid the political turmoil. Months later the company revived the offering with a lower fundraising target and on Wednesday it kicked off a week-long roadshow, seeking to sell 500m shares to investors.


Jack Ma, the Alibaba founder who retired as executive chairman this year, has close ties to China’s ruling Communist party. He has said on several occasions, including in an interview with the Financial Times, that he would happily hand over all of his businesses to the party if he were asked to do so.

In the run-up to the company’s $25bn initial public offering in New York five years ago, Mr Ma brought in investors including China’s sovereign investment fund CIC International and Boyu Capital, a private equity fund co-founded by Jiang Zhicheng, grandson of former president Jiang Zemin.

The listing could be “intended as a ‘political message’ of support for Hong Kong as a financial centre in what are, after all, unprecedented times in the city”, said Philippe Espinasse, a former head of Asian equity capital markets at Nomura.

Alibaba’s listing will also be the first in Hong Kong to dispense with offering physical copies of its prospectus, piles of which are typically stacked up in banks and handed out to retail investors.

The company says the move is for environmental reasons but speed is a factor too. Jason Elder, a partner at law firm Mayer Brown, said going paperless makes sense due to the “sheer logistical challenges of printing that many books and getting them delivered”.

“The way retail and institutional bookbuilds have always been done exposes offerings to more market volatility and potentially damaging market events over a longer pricing window,” Mr Elder added. “Reducing that window should improve Hong Kong’s standing because you’re allowing a company to build a book and price more quickly.”

Alibaba’s existing listing in New York also helped expedite its Hong Kong fundraising. “You can’t overstate that point,” said Stephen Peepels, head of law firm Hogan Lovells’ US securities practice in Asia-Pacific. The Hong Kong stock exchange, he added, “wouldn’t completely rubber stamp it”, but it would not have as many questions as it would for a company making a first move on to the public market.

The Alibaba offering might also put the Hong Kong bourse back on track to retain its listings crown for another year. If bankers execute an option to sell an additional 15 per cent of shares to investors, the secondary listing could be enough to push Hong Kong’s year-to-date total above the $32.5bn raised on New York’s Nasdaq, according to Dealogic data.

“It’s not as if you’re going to have tear gas wafting through the listing ceremony,” said Mr Howie.

>>> What to look at today - 19th of November 2019

U.S. stock futures were little changed and European ones edged up on Tuesday as investors continued to await signs of progress in U.S.-China trade negotiations.
Asia saw a mixed session, with stocks climbing in Sydney and Shanghai and dipping in Tokyo and Seoul. Hong Kong equities climbed again despite continuing unrest in the city, further recouping some of last week’s losses. Monday, the S&P 500 notched another record in a lackluster session. Oil prices added to their Monday decline. The dollar was little changed, while the pound held gains. Treasuries nudged higher.


Macro :
- Trump Says He ‘Protested’ to Powell About U.S. Interest Rates

Keep an eye on :
- AC FP : Accor to Sell 5.2% of Accorinvest For EU204M to Existing Hldrs
- ADKO AV : Addiko Defers Planned Tier 2 as Price Too High, SREP Unclear
- AGS BB : Ageas Starts Cash Tender for Outstanding FRESH Securities
- AT1 GY : Aroundtown Agrees to Buy TLG Immobilien in $3.4 Billion Deal
- ALC SW :ALCON 3Q: PanOptix in Focus as Analysts Watch Outlook
- BIOAB SS : Sonovo View, BioArctic Study, Sobi: European Health Pre-Market
- CO FP : Casino Signs EU2b Revolving Credit Facility Maturing Oct. 2023
- DIA LN : Dialight Sees FY Ebit GBP5m-GBP8m After ‘Very Weak’ Oct. Results
- DRX LN : Drax Targets Subsidy-Free Power From Biomass Plants by 2027
- EZJ LN : EasyJet Full Year Headline Profit Pretax Meets Estimates
- ETL FP : Eutelsat Looks to Engage With FCC on Frequency Auction Plan
- BAER SW : Julius Baer Launches Share Buyback Program of up to CHF400m (2)
- KLR LN : Keller Is More Reassuring, But Uncertainty Remains: Jefferies
- MRO LN : Melrose Says It’s Trading in Line With Expectations for 2019 (1)
- MOR GY : MorphoSys' B-Mind Trial Passing Interim Is Another Win: React
- NKIA FH : Nokia Wins Contract in Support of Docomo Pacific on Marianas 5G
- PLP LN : Polypipe Sales Slowdown Clear, But No Surprise, Says Jefferies
- RHIM LN : RHI Magnesita Holders GP Investments to Offer 1.9m Shrs
- ROVIO FH : Odey Reports 5.21% Stake in Rovio; Shares Pare Losses
- SESG FP : C-Band Alliance to Seek Alternative to FCC Auction Plan
- SMIN LN : Smiths Is Said to Kick Off Sale of $3 Billion Medical Business
- STOB LN : M&G, Ruffer in Talks Over Eddie Stobart Rescue Plan: Telegraph
- SOON SW : Sonova CEO Bets on R&D Investments to Keep Momentum Going
- SZU GY : Sugar Producer Suedzucker to Close Export Sales Office: Reuters
- SWEDA SS :Estonian FSA Finds Signs of Criminal Offenses at Swedbank Unit
- TIT IM : Telecom Italia In Line With 2019 Goals, CEO Tells Sole
- TKA GY : Thyssenkrupp Said to Tap Citi to Review Industrial Solutions Arm
- TTG LN : TT Electronics Sees Weak Trend Continuing; Buys Excelitas Unit
- VIV FP : Taylor Swift Is Cleared to Perform Her Old Hits at Awards Show
- VOW3 GY : Volkswagen Sued by Supplier Alleging Anticompetitive Behavior
- WLN : SIX Already Raised Money From Worldline for BME Bid

>>> Europe : Brokers Upgrades & Downgrades - 19th of November 20

>>> Up
* Acerinox Raised to Overweight at JPMorgan; PT 11 euros
* 1&1 Drillisch Raised to Buy at Citi
* BME Raised to Hold at Grupo Santander; PT 34.56 euros
* Intertek Raised to Buy at Jefferies; PT 6,100 pence
* Takeaway Raised to Outperform at Credit Suisse; PT 95 euros
* Telefonica Raised to Buy at Nord/LB; PT 8 euros

>>> Down
* B&M European Cut to Neutral at Citi
* B&M Cut at Citi With Limited Earnings Catalysts Seen Ahead
* Consort Medical Cut to Hold at Stifel; PT 1,010 pence
* Consort Medical Cut to Hold at Panmure Gordon; PT 1,010 pence
* Demant Cut to Hold at ABG; PT 204 kroner
* Diploma Cut to Neutral at JPMorgan; PT 1,730 pence
* Draegerwerk Cut to Sell at Hauck & Aufhaeuser
* Metrovacesa Cut to Equal-Weight at Morgan Stanley
* Prismi Cut to Underperform at EnVent S.p.A.; PT 1.27 euros
* Recipharm Cut to Hold at Handelsbanken; PT 155 kronor
* Zealand Pharma Cut to Hold at Jefferies; PT 235 kroner

>>> Initiation
* Forterra Rated New Buy at Canaccord; PT 330 pence
* Ibstock Rated New Hold at Canaccord; PT 260 pence
* TFF Group Rated New Buy at Berenberg; PT 43 euros
* Verallia Sasu Rated New Hold at Berenberg; PT 32 euros
* Vidrala Rated New Buy at Berenberg; PT 98 euros

>>> Call
* Intertek Raised as Jefferies Sees ‘Compelling Entry Point’
* Recipharm Cut to Hold at Handelsbanken; Deal Seen Value Dilutive
* Siemens Price Target Raised at Deutsche Bank After Spinoff Plans